- 1 hr ago What You Need To Know About The Ranna Puja (Cooking Festival) In West Bengal
- 1 hr ago Kangana Ranaut's Latest Airport Wardrobe Includes Breezy And Boss Lady Outfits
- 1 hr ago How To Get Nushrat Bharucha’s Glossy Make-up And Wet Hair Look
- 1 hr ago Dream Girl Actress Nushrat Bharucha Has Long Dress Goals For Girls With Average Height
- Sports BCCI election runs into rough weather over cooling off clause
- Automobiles Mahindra Car Sales India August 2019: Bolero Becomes Brand’s Top-Seller Yet Again
- Movies This Video of Taimur Speaking Toddler Language Is The CUTEST Thing You Will See On The Internet
- News Held for drunk riding, Florida couple have sex inside police car
- Finance Airtel Payments Bank Launches "Bharosa" Savings Account
- Technology Exclusive: Vivo U10 To Offer 6.35" Halo Full-View Display, 5,000mAh Battery And 15W Charger In Box
- Education NIOS Admit Card Released For Class 10 And 12 Sep/Oct 2019 Board Exam
- Travel Cycling for beginners: The basics any beginner cyclists should know
A therapy using a form of Vitamin B3 can potentially prevent melanoma - a deadly skin cancer - according to scientists, including one of Indian origin. Researchers from University of Sydney in Australia found that nicotinamide can help reduce or reverse DNA damage, inflammation, and immunosuppression caused by ultraviolet radiation.
The cost of nicotinatimide is about USD 10 per month if taken at one gramme per day as recommended, researchers said. Randomised placebo controlled trials are now warranted to determine its efficacy and safety for melanoma prevention, they said. Ultraviolet radiation (UVR) causes DNA damage in melanocytes by producing photolesions such as cyclobutane pyrimidine dimers and 8-oxo-7-hydrodeoxyguanosine.
The production of reactive oxygen species by UVR also induces inflammatory cytokines that, together with the inherent immunosuppressive properties of UVR, propagate carcinogenesis, researchers said. Nicotinamide (Vitamin B3) enhances DNA repair, modulates the inflammatory environment produced by UVR, and reduces UV- induced immunosuppression.
As nicotinamide reduces the incidence of actinic keratoses and nonmelanoma skin cancers in high-risk individuals and enhances repair of DNA damage in melanocytes, it is a promising agent for the chemoprevention of melanoma in high-risk populations.
"Nicotinamide has been show in a clinical trial - called ONTRAC - to reduce the incidence of non-melanoma skin cancer in high-risk individuals and it would be worthwhile to determine whether it would also be useful for high-risk melanoma patients," said Gary Halliday from University of Sydney. The study was published in the Photodermatology, Photoimmunology and Photomedicine.